Business description: C-Rad AB

C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.

Number of employees: 98

Sales by Activity: C-Rad AB

Fiscal Period: December 2021 (SEK) 2022 (SEK) 2023 (SEK) 2024 (SEK) 2025 (SEK)

Positioning

261M 301M 425M 469M 442M

Geographical breakdown of sales: C-Rad AB

Fiscal Period: December 2021 (SEK) 2022 (SEK) 2023 (SEK) 2024 (SEK) 2025 (SEK)

EMEA (Excluding Sweden)

- - - - 168M

APAC

- - 119M 210M 167M

Americas

- - 85.97M 72.7M 98.75M

Sweden

21.73M 8.67M - - 8.57M

South and Latin America

655K 689K - - -

Dach (Germany, Austria, Switzerland)

40.6M 31.88M - - -

The Rest of The Nordic Countries

5.37M 12.11M - - -

EMEA

- - 220M 186M -

France

13.91M 15.27M - - -

ROE (Other Europe)

46.27M 77.98M - - -

Asia

82.07M 83.99M - - -

USA

50.55M 70.75M - - -

Executive Committee: C-Rad AB

Manager TitleAgeSince
Chief Executive Officer 56 01/02/2026
Chief Executive Officer 49 20/10/2025
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer 50 -
Corporate Officer/Principal 52 31/03/2026

Composition of the Board of Directors: C-Rad AB

Director TitleAgeSince
Director/Board Member 52 31/12/2016
Director/Board Member 60 06/05/2021
Chairman 61 04/05/2023
Director/Board Member 60 04/05/2023
Director/Board Member 66 04/05/2023
Director/Board Member 55 22/07/2007

Shareholders: C-Rad AB

NameStocks%Valuation
Svea Bank AB
11.93 %
3,924,969 11.93 % 14 M kr
9.926 %
3,266,170 9.926 % 12 M kr
Cervantes Capital AB
9.521 %
3,132,758 9.521 % 12 M kr
5.197 %
1,710,018 5.197 % 6 M kr
4.863 %
1,600,000 4.863 % 6 M kr
NameStocks%Valuation
44.01 %
379,762 44.01 % 1 M kr
30.49 %
263,125 30.49 % 965 908 kr
Cervantes Capital AB
13.91 %
120,000 13.91 % 440 509 kr
Svea Bank AB
11.59 %
100,000 11.59 % 367 091 kr

Holdings: C-Rad AB

NameStocks%Valuation
785,5002.39% 3 M $

Company details: C-Rad AB

C-RAD AB

Sjukhusvaegen 12K

753 09, Uppsala

+46 18 666 930

http://www.c-rad.com
address C-Rad AB(CRAD B)

Other Advanced Medical Equipment & Technology

Change 5-day change 1-year change 3-year change Capi.($)
+1.79%+3.64%+6.05%+18.34% 115M
+0.35%-2.99%+20.52%+31.06% 242B
+1.09%-4.65%-0.43%-0.76% 150B
-2.32%-3.27%-13.35%+36.07% 138B
-1.46%-3.01%-56.23%-17.35% 61.74B
-0.05%-1.32%+10.48%+22.34% 49.08B
+0.66%+0.19%-20.53%-20.70% 47.43B
+0.66%-2.90%+18.46%+52.17% 47.3B
-3.05%-2.62%-7.75%+36.49% 44.25B
-0.08%-1.92%+29.48%+60.45% 41.78B
Average -0.24%-1.89%-1.33%+21.81% 82.28B
Weighted average by Cap. -0.29%-3.27%+1.08%+21.95%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
34.20SEK
Average target price
45.00SEK
Spread / Average Target
+31.58%

Quarterly revenue - Rate of surprise